Homocysteine levels and early heart relaxation changes in newly diagnosed high blood pressure
Official title: Relationship Between Elevated Homocysteine Levels and Early Diastolic Dysfunction in Newly Diagnosed Hypertensive Patients
Run by Necmettin Erbakan University · NCT07480265 · Data updated 2026-11-12
See if higher blood homocysteine is linked to early diastolic (heart relaxation) problems in adults recently diagnosed with high blood pressure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Necmettin Erbakan University Academic / other |
| Locations | 1 site (Konya, Meram) |
| Status | Recruiting |
| Started | June 2, 2025 |
| Main results expected | December 2027 |
| Study ends | March 2028 |
| Registry record updated | March 24, 2026 |
| Trial ID | NCT07480265 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a new diagnosis of essential hypertension within the past six months who can complete clinic visits, ambulatory blood pressure monitoring, blood draws, ECG, and transthoracic echocardiography are ideal candidates.
✕Probably not a fit
Patients with resistant or secondary hypertension, known heart failure, atrial fibrillation/flutter, chronic kidney disease, current folate/B12/B6 supplementation, or inadequate echocardiographic image quality are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center observational cohort enrolling at least 500 adults diagnosed with essential hypertension within the previous six months. Participants undergo clinical evaluation, ambulatory blood pressure monitoring, ECG, laboratory testing including pooled plasma homocysteine measurement, and comprehensive transthoracic echocardiography with diastolic function and strain analysis when image quality permits. Participants are categorized by a homocysteine threshold of 15 µmol/L and groups are compared for diastolic dysfunction and left ventricular and atrial global longitudinal strain parameters. Clinical, laboratory, and echocardiographic data will also be used to develop a machine-learning model to help predict H-type hypertension.
Why it matters
Potential benefit: If successful, the findings could help identify people with new high blood pressure who already have subtle heart dysfunction so clinicians can monitor or treat them earlier.
How similar studies have gone: Prior studies have linked elevated homocysteine to vascular and myocardial injury, but few large prospective cohorts have specifically tested its association with early diastolic dysfunction in newly diagnosed hypertension, so the approach is partly supported but still relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * Newly diagnosed essential hypertension within the previous 6 months * Ability and willingness to provide informed consent * Availability for clinical evaluation, laboratory testing, ambulatory blood pressure monitoring, electrocardiography, and transthoracic echocardiography Exclusion Criteria: * Resistant hypertension * Secondary hypertension * Acute coronary syndrome within the previous 6 months * Major surgery within the previous 6 months * Known heart failure * Pulmonary hypertension * Congenital heart disease * Atrial fibrillation or atrial flutter * Moderate or severe valvular heart disease * Chronic kidney disease * Anemia * Current folate, vitamin B12, or vitamin B6 supplementation or treatment * Inadequate echocardiographic image quality for strain analysis * Known systemic conditions that may significantly affect plasma homocysteine levels
Where it's running
-
Necmettin Erbakan University Meram Faculty of Medicine
Konya, Meram, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: yunus emre yavuz, MD — Necmettin Erbakan University
- Study coordinator: yunus emre yavuz, MD
- Email: eyavuz@erbakan.edu.tr
- Phone: +90 5306069194
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Isometric Handgrip Exercise to Lower Blood Pressure in Pregnant Women
This study tests whether doing isometric handgrip exercises can help lower blood pressure in pregnant women, including those with chronic hypertension.
-
Investigating microcirculation with non-invasive devices in adults with or at risk for CKD
This study tests two non-invasive devices (HEMI and SPG-NINOX) to see how small blood vessels behave in adults with or at risk for chronic kidney disease, hypertension, or type 2 diabetes.
-
Mobile home BP monitoring with coaching after high blood pressure from pregnancy
This program tests whether a home blood pressure monitoring system plus virtual coaching can help midlife women, 10–20 years after a hypertensive pregnancy, manage high blood pressure better than usual care.
-
Low energy availability and high blood pressure in Division I HBCU athletes
This project will test whether not eating enough for heavy training (low energy availability) is linked to higher blood pressure and stiffer arteries in Division I HBCU athletes ages 18–25.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.